HARTFORD HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1998-01-01

Employees: 1K

Market Cap: -

Website: https://hhchealth.org

Clinical Trials

Catheter Management After Pelvic Reconstructive Surgery

Not Applicable

Completed

Conditions: Urinary Retention Postoperative
Pelvic Organ Prolapse

Interventions: Device: Plug-unplug catheter management
Device: Continuous drainage catheter management

First Posted Date: 2017-03-06

Last Posted Date: 2019-02-04

Lead Sponsor: Hartford Hospital

Target Recruit Count: 96

Registration Number: NCT03071211

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Effect of Local Anesthesia on Postoperative Pain Following Sacrospinous Ligament Fixation

Not Applicable

Conditions: Pelvic Organ Prolapse

Interventions: Drug: Bupivacaine liposomal
Drug: Lidocaine

First Posted Date: 2016-09-07

Last Posted Date: 2016-10-12

Lead Sponsor: Hartford Hospital

Target Recruit Count: 30

Registration Number: NCT02890199

Locations: 🇺🇸
Hartford Hospital, Urogynecology Division, Hartford, Connecticut, United States

An Evaluation of Maternal Position During Cesarean Delivery

Not Applicable

Conditions: Cesarean Section

Interventions: Procedure: Supine
Procedure: Left uterine displacement

First Posted Date: 2016-08-19

Last Posted Date: 2018-08-01

Lead Sponsor: Hartford Hospital

Target Recruit Count: 120

Registration Number: NCT02872181

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Development of an Anxiety Sensitivity-Based Intervention for Substance Use and Anxiety Comorbidity

Phase 2

Completed

Conditions: Other (or Unknown) Substance Use Disorders

Interventions: Behavioral: Psychotherapy (Anxiety Sensitivity Intervention)

First Posted Date: 2016-01-28

Last Posted Date: 2016-03-28

Lead Sponsor: Hartford Hospital

Target Recruit Count: 41

Registration Number: NCT02667015

Locations: 🇺🇸
Institute of Living/Hartford Hospital, Hartford, Connecticut, United States

Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Phase 1

Completed

Conditions: Diabetes
Wound Infection
Healthy Volunteers

Interventions: Drug: Tedizolid
Procedure: Microdialysis Catheter Insertion

First Posted Date: 2015-12-03

Last Posted Date: 2019-01-15

Lead Sponsor: Hartford Hospital

Target Recruit Count: 18

Registration Number: NCT02620787

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

Phase 1

Completed

Conditions: Diabetes
Wound Infection
Healthy Volunteers

Interventions: Drug: Ceftolozane/tazobactam
Procedure: Microdialysis Catheter Insertion

First Posted Date: 2015-12-03

Last Posted Date: 2019-01-15

Lead Sponsor: Hartford Hospital

Target Recruit Count: 16

Registration Number: NCT02620774

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Ramelteon Prevention of Delirium - RCT

Phase 4

Conditions: Delirium

Interventions: Drug: Placebo
Drug: ramelteon

First Posted Date: 2015-10-01

Last Posted Date: 2018-08-01

Lead Sponsor: Hartford Hospital

Target Recruit Count: 240

Registration Number: NCT02564939

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Overactive Bladder Education

Not Applicable

Terminated

Conditions: Urinary Bladder, Overactive
Urinary Incontinence, Urge

Interventions: Other: Overactive Bladder Care Plan counseling

First Posted Date: 2015-07-22

Last Posted Date: 2015-12-31

Lead Sponsor: Hartford Hospital

Target Recruit Count: 22

Registration Number: NCT02505607

Locations: 🇺🇸
Hartford Hospital, Urogynecology Division, West Hartford, Connecticut, United States

The REACT-ICD Trial

Phase 1

Conditions: Atrial Tachyarrhythmia
Atrial Fibrillation

Interventions: Device: Reactive ATP

First Posted Date: 2015-05-08

Last Posted Date: 2016-12-23

Lead Sponsor: Hartford Hospital

Target Recruit Count: 6

Registration Number: NCT02439424

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Phenazopyridine for Confirmation of Ureteral Patency

Not Applicable

Completed

Conditions: Cystoscopy

Interventions: Drug: Phenazopyridine

First Posted Date: 2015-04-22

Last Posted Date: 2016-12-05

Lead Sponsor: Hartford Hospital

Target Recruit Count: 107

Registration Number: NCT02424149

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy